Quality indicators for the care of heart failure in vulnerable elders

Journal of the American Geriatrics Society

Volumn 55, Issue SUPPL. 2, 2007, Pages

  Heidenreich, Paul A ^a,c   Fonarow, Gregg C ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

Congestive heart failure; Frail elderly; Health care quality indicators

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METOPROLOL; PLACEBO; TRANDOLAPRIL;

ANAMNESIS; CLINICAL TRIAL; COUNSELING; DIETARY INTAKE; DRUG BLOOD LEVEL; ELDERLY CARE; ELECTROCARDIOGRAM; EVIDENCE BASED MEDICINE; FOLLOW UP; FUNCTIONAL STATUS; HEALTH CARE QUALITY; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE FUNCTION; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY;

AGED; BLOOD UREA NITROGEN; CARDIAC VOLUME; CARDIOVASCULAR AGENTS; CREATININE; ELECTROLYTES; EVIDENCE-BASED MEDICINE; FRAIL ELDERLY; HEART FAILURE; HUMANS; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34848839844     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01341.x     Document Type: Review

References (54)

1. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005 46 : 1116 1143.
2. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacological approaches. Heart Failure Society of America. J Card Fail 1999 5 : 357 382.
3. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001 22 : 1527 1560.
4. Bonow RO, Bennett S, Casey DE Jr. et al. ACC/AHA clinical performance measures for adults with chronic heart failure: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation 2005 112 : 1853 1887.
5. Fonarow GC. Quality indicators for the management of heart failure in vulnerable elders. Ann Intern Med 2001 135 (8 Part 2) : 694 702. No abstract available.
6. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992 327 : 685 691.
7. Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992 327 : 669 677.
8. Kober L, Torp-Pedersen C, Carlsen JE et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995 333 : 1670 1676.
9. Jong P, Yusuf S, Rousseau MF et al. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: A follow-up study. Lancet 2003 361 : 1843 1848.
10. Shekelle PG, Rich MW, Morton SC et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: A meta-analysis of major clinical trials. J Am Coll Cardiol 2003 41 : 1529 1538.
11. Kahn KL, Rogers WH, Rubenstein LV et al. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system. JAMA 1990 264 : 1969 1973.
12. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation 1998 97 : 282 289.
13. Grossman E, Messerli FH. Diabetic and hypertensive heart disease. Ann Intern Med 1996 125 : 304 310.
14. Guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 1991 17 : 543 589.
15. Demakis JG, Proskey A, Rahimtoola SH et al. The natural course of alcoholic cardiomyopathy. Ann Intern Med 1974 80 : 293 297.
16. Regan TJ. Alcohol and the cardiovascular system. JAMA 1990 264 : 377 381.
17. Gadsboll N, Hoilund-Carlsen PF, Nielsen GG et al. Interobserver agreement and accuracy of bedside estimation of right and left ventricular ejection fraction in acute myocardial infarction. Am J Cardiol 1989 63 : 1301 1307.
18. Mattleman SJ, Hakki AH, Iskandrian AS et al. Reliability of bedside evaluation in determining left ventricular function: Correlation with left ventricular ejection fraction determined by radionuclide ventriculography. J Am Coll Cardiol 1983 1 (2 Part 1) : 417 420.
19. Khot UN, Jia G, Moliterno DJ et al. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: The enduring value of Killip classification. JAMA 2003 290 : 2174 2181.
20. Stapleton JF, Segal JP, Harvey WP. The electrocardiogram of myocardopathy. Prog Cardiovasc Dis 1970 13 : 217 239.
21. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986 73 : 257 267.
22. Dei Cas L, Metra M, Leier CV. Electrolyte disturbances in chronic heart failure: Metabolic and clinical aspects. Clin Cardiol 1995 18 : 370 376.
23. Senni M, Rodeheffer RJ, Tribouilloy CM et al. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol 1999 33 : 164 170.
24. Packer M. Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure. Am J Cardiol 1990 65 : 45E 51E, discussion 52E.
25. Steiness E, Olesen KH. Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy. Br Heart J 1976 38 : 167 172.
26. Packer M, Lee WH, Medina N et al. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med 1987 106 : 346 354.
27. Doughty RN, Rodgers A, Sharpe N et al. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J 1997 18 : 560 565.
28. Heidenreich PA, Keeffe B, McDonald KM et al. Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death. Am Heart J 2002 144 : 422 430.
29. Lechat P, Packer M, Chalon S et al. Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998 98 : 1184 1191.
30. Bonet S, Agusti A, Arnau JM et al. Beta-adrenergic blocking agents in heart failure: Benefits of vasodilating and non-vasodilating agents according to patients' characteristics: A meta-analysis of clinical trials. Arch Intern Med 2000 160 : 621 627.
31. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 2001 134 : 550 560.
32. Poole-Wilson PA, Swedberg K, Cleland JG et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): Randomised controlled trial. Lancet 2003 362 : 7 13.
33. Dulin BR, Haas SJ, Abraham WT et al. Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials. Am J Cardiol 2005 95 : 896 898.
34. Flather MD, Shibata MC, Coats AJ et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005 26 : 215 225.
35. Packer M. Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy. Circulation 1990 82 : 2254 2257.
36. Elkayam U, Amin J, Mehra A et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990 82 : 1954 1961.
37. Ryman KS, Kubo SH, Lystash J et al. Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure. Am J Cardiol 1986 58 : 583 588.
38. Goldstein RE, Boccuzzi SJ, Cruess D et al. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and The Multicenter Diltiazem Postinfarction Research Group. Circulation 1991 83 : 52 60.
39. Elkayam U, Weber L, McKay C et al. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. Am J Cardiol 1985 56 : 560 566.
40. Kostis JB, Lacy CR, Cosgrove NM et al. Association of calcium channel blocker use with increased rate of acute myocardial infarction in patients with left ventricular dysfunction. Am Heart J 1997 133 : 550 557.
41. Packer M, O'Connor CM, Ghali JK et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective randomized amlodipine survival evaluation study group. N Engl J Med 1996 335 : 1107 1114.
42. Cohn JN, Ziesche S, Smith R et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-heart failure trial (V-HeFT) study group. Circulation 1997 96 : 856 863.
43. Gottlieb SS, Kukin ML, Yushak M et al. Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure. Ann Intern Med 1989 110 : 505 509.
44. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992 327 : 227 233.
45. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993 270 : 1589 1595.
46. Doval HC, Nul DR, Grancelli HO et al. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994 344 : 493 498.
47. Singh SN, Fletcher RD, Fisher SG et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995 333 : 77 82.
48. Gheorghiade M, Ferguson D. Digoxin. A neurohormonal modulator in heart failure? Circulation 1991 84 : 2181 2186.
49. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 336 : 525 533.
50. Koelling TM, Johnson ML, Cody RJ et al. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation 2005 111 : 179 185.
51. Ghali JK, Kadakia S, Cooper R et al. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 1988 148 : 2013 2016.
52. Gwadry-Sridhar FH, Flintoft V, Lee DS et al. A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med 2004 164 : 2315 2320.
53. Piepoli MF, Davos C, Francis DP et al. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004 328 : 189.
54. Fonarow GC, Stevenson LW, Walden JA et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997 30 : 725 732.